These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15650299)

  • 21. Clinical characteristics of a Dutch DFNA9 family with a novel COCH mutation, G87W.
    Pauw RJ; Collin RW; Huygen PL; Hoefsloot LH; Kremer H; Cremers CW
    Audiol Neurootol; 2007; 12(2):77-84. PubMed ID: 17264471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Audiometric characteristics of a Dutch family linked to DFNA15 with a novel mutation (p.L289F) in POU4F3.
    Pauw RJ; van Drunen FJ; Collin RW; Huygen PL; Kremer H; Cremers CW
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):294-300. PubMed ID: 18347256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual impairment in Finnish Usher syndrome type III.
    Plantinga RF; Pennings RJ; Huygen PL; Sankila EM; Tuppurainen K; Kleemola L; Cremers CW; Deutman AF
    Acta Ophthalmol Scand; 2006 Feb; 84(1):36-41. PubMed ID: 16445437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype of DFNA11: a nonsyndromic hearing loss caused by a myosin VIIA mutation.
    Tamagawa Y; Ishikawa K; Ishikawa K; Ishida T; Kitamura K; Makino S; Tsuru T; Ichimura K
    Laryngoscope; 2002 Feb; 112(2):292-7. PubMed ID: 11889386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expressivity of hearing loss in cases with Usher syndrome type IIA.
    Sadeghi AM; Cohn ES; Kimberling WJ; Halvarsson G; Möller C
    Int J Audiol; 2013 Dec; 52(12):832-7. PubMed ID: 24160897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of two truncating mutations in USH2A causes more severe and progressive hearing impairment in Usher syndrome type IIa.
    Hartel BP; Löfgren M; Huygen PL; Guchelaar I; Lo-A-Njoe Kort N; Sadeghi AM; van Wijk E; Tranebjærg L; Kremer H; Kimberling WJ; Cremers CW; Möller C; Pennings RJ
    Hear Res; 2016 Sep; 339():60-8. PubMed ID: 27318125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mutations in MYO7A and USH2A in Usher syndrome.
    Maubaret C; Griffoin JM; Arnaud B; Hamel C
    Ophthalmic Genet; 2005 Mar; 26(1):25-9. PubMed ID: 15823922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pure tone audiogram and speech audiometry in patients with hereditary motor and sensory neuropathy.
    Alcin B; Vatovec J; Zargi M
    Pflugers Arch; 2000; 439(3 Suppl):R202-3. PubMed ID: 10653191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current audiological tests in the diagnosis of sensorineural hearing loss caused by noise].
    Diskalenko VV
    Vestn Otorinolaringol; 1990; (6):12-4. PubMed ID: 2075669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Roles of spectral cues in Mandarin tone perception for sensorineural hearing-impaired patients].
    Wang S; Mannell R; Newall P; Liu B; Zhang H; Han DM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Feb; 47(2):122-6. PubMed ID: 22455810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic studies in Spanish patients with Usher syndrome type II: description of new mutations and evidence for a lack of genotype--phenotype correlation.
    Bernal S; Medà C; Solans T; Ayuso C; Garcia-Sandoval B; Valverde D; Del Rio E; Baiget M
    Clin Genet; 2005 Sep; 68(3):204-14. PubMed ID: 16098008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usher type I syndrome in children: genotype/phenotype correlation and cochlear implant benefits].
    Blanchet C; Roux AF; Hamel C; Ben Salah S; Artières F; Faugère V; Uziel A; Mondain M
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):137-43. PubMed ID: 18323324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of visual, auditory, and olfactory function in Usher syndrome.
    Seeliger M; Pfister M; Gendo K; Paasch S; Apfelstedt-Sylla E; Plinkert P; Zenner HP; Zrenner E
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):301-7. PubMed ID: 10208263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relation between pure tone audiometry and speech audiometry in various hearing-impaired listeners].
    He LP
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(1):29-31, 59. PubMed ID: 8352994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hearing loss in Usher syndrome type II is nonprogressive.
    Reisser CF; Kimberling WJ; Otterstedde CR
    Ann Otol Rhinol Laryngol; 2002 Dec; 111(12 Pt 1):1108-11. PubMed ID: 12498372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic characterization of a DFNA6 family showing progressive low-frequency sensorineural hearing impairment.
    Tóth T; Pfister M; Zenner HP; Sziklai I
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):201-6. PubMed ID: 16043233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of speech audiometry by bone conduction in hearing-impaired adults.
    Karlsen EA; Goetzinger CP
    J Aud Res; 1980 Apr; 20(2):89-95. PubMed ID: 7345063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Children's speech recognition scores: the Speech Intelligibility Index and proficiency factors for age and hearing level.
    Scollie SD
    Ear Hear; 2008 Aug; 29(4):543-56. PubMed ID: 18469717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audibility-index predictions of normal-hearing and hearing-impaired listeners' performance on the connected speech test.
    Sherbecoe RL; Studebaker GA
    Ear Hear; 2003 Feb; 24(1):71-88. PubMed ID: 12598814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of mutations in USH2A in British patients with Usher syndrome type II.
    Leroy BP; Aragon-Martin JA; Weston MD; Bessant DA; Willis C; Webster AR; Bird AC; Kimberling WJ; Payne AM; Bhattacharya SS
    Exp Eye Res; 2001 May; 72(5):503-9. PubMed ID: 11311042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.